2021
DOI: 10.1016/j.ejmech.2021.113216
|View full text |Cite
|
Sign up to set email alerts
|

Current status and future prospects of p38α/MAPK14 kinase and its inhibitors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
26
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 64 publications
(31 citation statements)
references
References 114 publications
1
26
0
Order By: Relevance
“…The rst two have been shown to be associated with in ammatory disease and angiogenesis. 37,38 PIK3CA is one of the most common mutation genes found in tumor types in recent years. 39 It is reported that mutations in this gene involve the occurrence of ovarian cancer in EM.…”
Section: Discussionmentioning
confidence: 99%
“…The rst two have been shown to be associated with in ammatory disease and angiogenesis. 37,38 PIK3CA is one of the most common mutation genes found in tumor types in recent years. 39 It is reported that mutations in this gene involve the occurrence of ovarian cancer in EM.…”
Section: Discussionmentioning
confidence: 99%
“…The downregulated expression of RUNX3 is consistent with the findings of these previous studies, suggesting that RUNX3 may protect against the development of sepsis. The other differentially expressed TF, MAPK14, plays an important role in initiating numerous conditions, including inflammation, cardiovascular diseases, and cancer [26] . MAPK14 can be activated by environmental stress and by various proinflammatory cytokines.…”
Section: Discussionmentioning
confidence: 99%
“…Compound 1m showed a concentrationdependent inhibitory effect against COX-2 and iNOS protein expression, especially at 10 µM concentration. Moreover, compound 1m markedly suppressed the phosphorylation of p38, a key molecule in regulating inflammation [20].…”
Section: Biological Evaluationmentioning
confidence: 96%